Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission

Bioclinical Test to Predict Nephropathia Epidemica Severity at Hospital Admission

We conducted a multicenter, retrospective cohort study of hospitalized patients with serologically proven nephropathia epidemica (NE) living in Ardennes Department, France, during 2000–2014 to develop a bioclinical test predictive of severe disease. Among 205 patients, 45 (22.0%) had severe NE. We f...

Full description

Bibliographic Details
Main Authors: Maxime Hentzien, Stéphanie Mestrallet, Pascale Halin, Laure-Anne Pannet, Delphine Lebrun, Moustapha Dramé, Firouzé Bani-Sadr, Jean-Marc Galempoix, Christophe Strady, Jean-Marc Reynes, Christian Penalba, Amélie Servettaz
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2018-06-01
Series:Emerging Infectious Diseases
Subjects:
hantavirus
acute kidney injury
Puumala virus
prognosis
France
Europe
Online Access:https://wwwnc.cdc.gov/eid/article/24/6/17-2160_article

Internet

https://wwwnc.cdc.gov/eid/article/24/6/17-2160_article

Similar Items